Biomarker Identification in Nonalcoholic Fatty Liver Disease via GC/MS

Postery | 2017 | LECOInstrumentace
GC/MSD, GC/TOF
Zaměření
Klinická analýza
Výrobce
Agilent Technologies, LECO
Přejít do knihovnyZobrazit PDF
PDF verze ke stažení a čtení
 

Podobná PDF

Untargeted Investigation of Non-Alcoholic Fatty Liver Disease Using Effective Mutiplatform GC-MS Instrumentation
Untargeted Investigation of Non-Alcoholic Fatty Liver Disease Using Effective Mutiplatform GC-MS Instrumentation
2017|Agilent Technologies|Postery
Effects of Increased Fructose Consumption and Inadequate Copper Intake on the Pathogenesis of Nonalcoholic Fatty Liver Disease (NAFLD): A Feces, Plasma and Liver Metabolomics Study
Effects of Increased Fructose Consumption and Inadequate Copper Intake on the Pathogenesis of Nonalcoholic Fatty Liver Disease (NAFLD): A Feces, Plasma and Liver Metabolomics Study
2016|Agilent Technologies|Postery
A Novel Benchtop Time-of-Flight GC-MS System for High Performance Analysis of Human Urine
A Novel Benchtop Time-of-Flight GC-MS System for High Performance Analysis of Human Urine
2016|Agilent Technologies|Postery
A Comprehensive GC-TOFMS Metabolomics Workflow
A Comprehensive GC-TOFMS Metabolomics Workflow
2022|LECO|Aplikace